Chart: Remarks From CDRH Director Feigal During AdvaMed Annual Meeting
This article was originally published in The Gray Sheet
Executive Summary
Remarks From CDRH Director Feigal During AdvaMed Annual MeetingYou may also be interested in...
Senate Drug Pricing Bill Lowers Manufacturer Discounts In Part D Catastrophic Phase
Revised bill released by the US Senate Finance Committee adjusts the manufacturer discount program in Medicare Part D and includes new provisions aimed at easing beneficiary cost sharing obligations.
Performance Criteria Issued On Magnetic Resonance Coils In New FDA Draft Guidance
Through a draft guidance, the US agency has established performance criteria for magnetic resonance coils, making the devices eligible for the standards-based Safety and Performance Based Pathway.
Global Scare Over Nitrosamine Impurities Extends To Diabetes Medication
Singapore recalls trigger international reaction as metformin is added to growing list of chronic medications found to contain NDMA.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: